Tema Heart & Health ETF (HRTS)
NASDAQ: HRTS · Real-Time Price · USD
35.82
-0.11 (-0.30%)
Feb 20, 2026, 4:00 PM EST - Market closed
HRTS Holdings Information
HRTS is an equity ETF with a total of 44 individual holdings. The top holdings are Eli Lilly and Company stock at 9.81%, Roche Holding AG at 5.47%, Johnson & Johnson at 4.86%, AstraZeneca at 4.76%, and Merck & Co. at 4.20%.
Total Holdings
44
Top 10 Percentage
47.29%
Asset Class
Equity
ETF Category
Health
Assets
55.14M
PE Ratio
22.43
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 9.81% |
| 2 | RHHBY | Roche Holding AG | 5.47% |
| 3 | JNJ | Johnson & Johnson | 4.86% |
| 4 | LON: AZN | AstraZeneca PLC | 4.76% |
| 5 | MRK | Merck & Co., Inc. | 4.20% |
| 6 | TMO | Thermo Fisher Scientific Inc. | 3.88% |
| 7 | UNH | UnitedHealth Group Incorporated | 3.83% |
| 8 | GILD | Gilead Sciences, Inc. | 3.70% |
| 9 | SWX: NOVN | Novartis AG | 3.50% |
| 10 | ABT | Abbott Laboratories | 3.27% |
| 11 | VRTX | Vertex Pharmaceuticals Incorporated | 3.05% |
| 12 | DHR | Danaher Corporation | 2.95% |
| 13 | ABBV | AbbVie Inc. | 2.88% |
| 14 | CPH: NOVO.B | Novo Nordisk A/S | 2.79% |
| 15 | BSX | Boston Scientific Corporation | 2.45% |
| 16 | BBIO | BridgeBio Pharma, Inc. | 2.39% |
| 17 | MDT | Medtronic plc | 2.38% |
| 18 | RVMD | Revolution Medicines, Inc. | 2.24% |
| 19 | BMY | Bristol-Myers Squibb Company | 2.11% |
| 20 | MCK | McKesson Corporation | 2.07% |
| 21 | AMGN | Amgen Inc. | 2.04% |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | 2.03% |
| 23 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.91% |
| 24 | EW | Edwards Lifesciences Corporation | 1.71% |
| 25 | TEVA | Teva Pharmaceutical Industries Limited | 1.65% |
As of Feb 19, 2026